12 Result(s)

Article

Autologous transplant vs oral chemotherapy and lenalidomide in newly diagnosed young myeloma patients: a pooled analysis

In newly diagnosed myeloma patients, upfront autologous transplant (ASCT) prolongs progression-free survival 1 (PFS1) compared with chemotherapy plus lenalidomide (CC+R). Salvage ASCT at first relapse may stil...

F Gay, S Oliva, M T Petrucci, V Montefusco, C Conticello, P Musto, L Catalano… in Leukemia (2017)

Article

A phase 2 study of three low-dose intensity subcutaneous bortezomib regimens in elderly frail patients with untreated multiple myeloma

This phase 2 trial evaluated three low-dose intensity subcutaneous bortezomib-based treatments in patients ⩾75 years with newly diagnosed multiple myeloma (MM). Patients received subcutaneous bortezomib plus o...

A Larocca, S Bringhen, M T Petrucci, S Oliva, A P Falcone, T Caravita… in Leukemia (2016)

Article

Lenalidomide and low-dose dexamethasone for newly diagnosed primary plasma cell leukemia

P Musto, V Simeon, M C Martorelli, M T Petrucci, N Cascavilla, F Di Raimondo… in Leukemia (2014)

Article

Lenalidomide cutaneous adverse event: a case of Stevens–Johnson syndrome (SJS) in a primary plasma cell leukaemia patient treated with lenalidomide and dexamethasone

A. Siniscalchi, A. Tendas, L. Morino, T. Dentamaro… in Supportive Care in Cancer (2012)

Article

Stem cell mobilization in patients with newly diagnosed multiple myeloma after lenalidomide induction therapy

Lenalidomide has raised concerns regarding its potential impact on the ability to collect stem cells for autologous stem cell transplantation, especially after prolonged exposure. The use of cyclophosphamide p...

F Cavallo, S Bringhen, G Milone, D Ben-Yehuda, A Nagler, E Calabrese… in Leukemia (2011)

Article

Cutaneous involvement in multiple myeloma and bortezomib

A. Siniscalchi, S. Fratoni, G. Santeusanio, G. Del Poeta… in Annals of Hematology (2009)

Article

High-dose therapy with autologous PBSC transplantation in the front-line treatment of Waldenstrom's macroglobulinemia

T Caravita, A Siniscalchi, A Tendas, L Cupelli, T Dentamaro… in Bone Marrow Transplantation (2009)

Article

Vasculogenic mimicry by bone marrow macrophages in patients with multiple myeloma

Bone marrow macrophages of patients with active and nonactive multiple myeloma (MM), monoclonal gammopathies of undetermined significance (MGUS) and benign anemia (controls) were stimulated for 7 days with vas...

C Scavelli, B Nico, T Cirulli, R Ria, G Di Pietro, D Mangieri, A Bacigalupo… in Oncogene (2008)

Article

Multiple myeloma: comparison of two dose-intensive melphalan regimens (100 vs 200 mg/m²)

Several trials have shown the superior impact of high-dose melphalan (usually 200 mg/m², MEL200) vs standard therapy in myeloma patients. Intermediate-dose melphalan (100 mg/m², MEL100) is also superior to the st...

A Palumbo, S Bringhen, A Bertola, F Cavallo, P Falco, M Massaia, B Bruno, C Rus… in Leukemia (2004)

Article

Enumeration of CD34⁺ hematopoietic progenitor cells for clinical transplantation: comparison of three different methods

Three different methods for determination of CD34⁺ cells in G-CSF-mobilized peripheral blood were compared. The methods were: the Milan/Mulhouse protocol, the ISHAGE guidelines for CD34⁺ cells enumeration and our...

A Venditti, A Battaglia, G Del Poeta, F Buccisano… in Bone Marrow Transplantation (1999)

Article

In vitro down-regulation of bcl-2 expression by all-trans retinoic acid in AML blasts

Using flow cytometry, we have investigated the effects of 0.5 μM all-trans–retinoic acid (ATRA) on bcl-2 expression in the blast cells of 25 acute myeloblastic leukemia (AML) patients and the HL-60 cell line afte...

F. Pisani, G. Del Poeta, G. Aronica, A. Venditti, T. Caravita… in Annals of Hematology (1997)